This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Ophthalmol. 2000;118:426-427.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Fomivirsen sodium is a new oligonucleotide drug that acts as an antisense compound to inhibit viral protein translation. It is given as an intravitreal injection weekly for 3 weeks and then every 3 weeks for maintenance.¹ We report on retinal toxic effects associated with fomivirsen.

Report of a Case

A 41-year-old man with human immunodeficiency virus infection was seen with zone 2 cytomegalovirus (CMV) retinitis in his right eye on July 15, 1998. He had been enrolled in a phase III drug trial for fomivirsen sodium at a dose of 330 µg for treatment in his left eye. He was receiving 3000 mg a day of oral ganciclovir sodium to treat systemic CMV viremia (not part of study protocol). He was enrolled in the study, per protocol, at a dose of 165 µg for treatment in his right eye. The first injection was given on July 22, 1998, and was repeated on July 29 . . . [Full Text of this Article]

Comment
Haris I. Amin, MD
Rockford, Ill

Everett Ai, MD; H. Richard McDonald, MD; Robert N. Johnson, MD
San Francisco, Calif

Corresponding author: Haris I. Amin, MD, Northern Illinois Retina, 4855 E State St, Rockford, IL 61108 (e-mail: retinaguy@earthlink.net).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhibition of Human Cytomegalovirus Replication by Benzimidazole Nucleosides Involves Three Distinct Mechanisms
Evers et al.
Antimicrob. Agents Chemother. 2004;48:3918-3927.
ABSTRACT | FULL TEXT  

Role of a Mutation in Human Cytomegalovirus Gene UL104 in Resistance to Benzimidazole Ribonucleosides
Komazin et al.
J. Virol. 2004;78:710-715.
ABSTRACT | FULL TEXT  

Resistance of Human Cytomegalovirus to the Benzimidazole L-Ribonucleoside Maribavir Maps to UL27
Komazin et al.
J. Virol. 2003;77:11499-11506.
ABSTRACT | FULL TEXT  

Pigmentary Retinopathy Associated With Intravitreal Fomivirsen
Uwaydat and Li
Arch Ophthalmol 2002;120:854-857.
FULL TEXT  

Intravitreal Delivery of Oligonucleotides by Sterically Stabilized Liposomes
Bochot et al.
IOVS 2002;43:253-259.
ABSTRACT | FULL TEXT  

Retinal Toxic Effects Associated With Intravitreal Fomivirsen
Freedman
Arch Ophthalmol 2001;119:458-458.
FULL TEXT